making waves in todays cannabis industry€¦ · cse: csi | otc:cadmf | fra:cwaa making waves in...

CSE: CSI | OTC:CADMF | FRA:CWAA

MAKING WAVES IN TODAYS CANNABIS INDUSTRY

With a strategic footprint across multiple regions, Chemesis is positioned to establish and grow new market opportunities..

… where others strive to raise millions only to lose millions, we’re building a business that stands on its own - TODAY.

Since late 2017, we have gone from conception to over $17.5 million in sales.

We are growing an impressive international distribution network and key regional brand partnerships.

Private label partners to bring high-quality products to markets we operate in.

Our acquisition strategy is already reaching new and exciting high value markets.

2Copyright © 2019, Chemesis International, Inc

Bringing new innovative consumption methods to consumers.

Largest seed-to-consumer cannabis operator in Puerto Rico.

CHEMESIS IS A MULTI-STATE, MULTI-NATIONAL, MULTI-SERVICESInnovator in the international cannabis industry

HIGHLIGHTS


KEY METRICS

7,000 AcresTotal Outdoor Grow

Capacity

Ethanol, BHO & CO2Extraction Capabilities

25Total Licenses across the

US, Puerto Rico, & Colombia

50,000 sq. ftTotal Manufacturing

Space Available

100,000 sq. ft.Indoor Grow

Design Capacity

25,000 sq. ft. active retail operations

Over 1,000 acres for outdoor cultivation in Colombia

10 active retail locations, plus 5 more under construction & development

Operating in North & South America

3 operational large-scale extraction facilities

3 parent brand product lines, 2 partner brand product lines

3 finished goods manufacturing facilities

2 Large-Scale packaging

& distribution facilities

Access to 6,000 acres of outdoor cultivation in Puerto Rico


MILESTONES

2018

Q1 Q2 Q3 Q4

2019 2020

• Chemesis begins publicly trading.

• Acquisition of California extraction facility.

• Acquired Natural Ventures Puerto Rico.

• Obtained exclusive rights to Quickstrips in Puerto Rico & California.

• Closed acquisitions of Colombian La Finca asset.

• Signed $4m USD annual purchase order.

• Acquired additional California extraction & manufacturing facility.

• Partnership with First Medical PR partnership for 6,000 acres of hemp cultivation.

• Launched CBD product catalogue in Puerto Rico.

• Began US multi-state expansion.

• Colombian asset begins process to expand to over 10,000 acres.

• Signed $6m USD annual minimum purchase order.

• Acquired controlling interest in GSRX Industries Inc.

• Signed two exclusive off-take supply agreements for hemp in Puerto Rico.

• Announced launch of Hemp Cigarettes & Tobacco-free cannabis chew

• Announced intention to spin out of La-Finca asset for a 1:1 share exchange

• Announced an exclusive partnership for the VICKI self-checkout retail solution.

$944,457 $3,406,413 $4,051,471 $4,700,834 $4,529,524


CORE DRIVERS#1 or #2 Brand in every category we compete in

Researching, developing & manufacturing quality-assured products

We manufacture to meet insource & wholesale product demands

Multi-year, incentive-based relationships with our distributors ensures long term relationships

Gain talent through acquisitions – increasing internal knowledge, ability and agility.

Focused quality assurance, customer responsiveness, & committed to shareholder value.

• Build Green Spirit Rx, Curador, Terapia, URB’N Fog.

• Borrow RDT Therapeutics, Quickstrip Oral Thin Strips.

• Expand into categories with strong brand focus.

• Partnership with Rapid Dose Therapeutics to develop and exclusively retail its QuickstripTM Oral Thin Strips in select markets.

Applying a balance of science & intuition to deliver industry leading yields

Standardizing retail model, distribution, and marketing spend

• State-of-the-art VividGro LED lighting.

• Environmental controls to reduce operating costs.

• Increase functional cultivation area.

• Consumer insights & metrics to drive innovation.

• Consumer loyalty to recruit, retain & build strong relationships.

• Systems & controls to ensure just-in-time delivery, reducing waste and optimizing efficiencies.


GLOBAL GROWTH STRATEGY

• Regulation will drive market entry.• Consumer demand will dictate retail store development. • Lean operating principles will scale manufacturing to support

optimal cost to grow, process, and create finished goods.


*Unattended IoT Vending Locations**Attended ‘Brick & Mortar’ Retail Outlets

LICENSES CURRENT 2025 VISION

Retail 14 800 unattended* 200 attended**

Manufacturing 6 25

Cultivation 5 15Retail

Manufacturing

Agriculture


CULTIVATION

Licensed for 5 commercial scale cultivars.Fully licensed 1,060 acres of outdoor hemp cultivation near Bogota, Colombia.

Chemesis will look to extend its prospects by an additional 10,000 acres withinthe next 3 years.

COLOMBIA

Partnerships with Universidad Nacional de Colombia and Universidad DistritalFrancisco Jose de Caldas to develop seed strains that improve yield of biomass and flower while shortening crop cycles.

PUERTO RICO

Advanced LED Lighting and environmental control system which provides efficiencies and consistent growth profiles.

Licensed cultivation of over 9,000lbs per year with continued growth to annualized capacity of 30,000lbs.

Partnership with First Medical bringing access to 1,000 acres of outdoor hemp cultivation. This partnership is expandable to an additional 5,000 acres.

Exclusive offtake agreements for high-potency hemp crops with cultivators across the island.

Images: Puerto Rico Facilities

*

*The Company intends on completing a spin-out transaction of La-Finca for a 1:1 share exchange.


MANUFACTURING

California• Extraction facility capable

of large-scale commercial ethanol, CO2 & BHO extraction.

• Finished goods manufacturing such as gels, sub lingual delivery products, tobacco-free chew, cartridges, and other consumer products.

Michigan• State approval to initiate

construction of a hemp processing facility.

• Received Hemp Cultivation & Processing Licensing across the state.

• Gained Gold Vendor Status to license, manufacture, distribute, and sell RDT’s proprietary QuickStripsTM.

Colombia• Currently in the process

of constructing a certified extraction facility and production lab under GMP standards, with international export capabilities.

Puerto Rico• BHO & CO2 extraction equipment

for medical cannabis.

• Finished goods manufacturing with products such as, tinctures, patches, edibles, liquids, capsules, and cartridges.

• Packaging & distribution throughout the island expandable for large scale global commercialization.

Images: California Facilities

*The Company intends on completing a spin-out transaction of La-Finca for a 1:1 share exchange.

*


RETAIL

Unattended IoT (internet of things) self-checkout solution for retail opportunities

• Technology includes artificial intelligence, facial & age verification, built in auto attendant with product education and promotion.

• Subscription based with an integrated consumer loyalty program.

• UV-C lighting kills bacteria & sanitizes product delivery.

Dispensaries are currently operationalacross the United States & Puerto Rico.

Chemesis is poised to grow and meetconsumer needs while navigating local,state & federal regulations.

ATTENDED UNATTENDED

Traditional Retail

Images: GSRX Dispensaries

An automated store-within-a-store& highly cost-effective use of capital.

Gives consumers what they want,when, where & how they want it.

The Future of Retail


BRAND ACCELERATION OUR BRAND PARTNERS BRING VALUE THROUGH QUALITY & PRODUCT CONSISTENCYDelivering Value Through Quality & Product Consistency

Chemesis is the only Gold Vendor that will deliver RDT’s proprietary QuickstripTM. QuickStrip™ technology.

Quick, Convenient, Precise, Discreet™ oral fast-dissolving drug delivery system that offers a No Smoke, No Smell, No Stigma™ product to consumers.

Rapid Dose Therapeutics

Your world is uniquely yours.It's personal and you live it onyour own terms.

URB’N Fog, Edibles & PrivateStash define your independentspirit and expresses your uniqueimpact on the world whilepowering your personalcreativity.

Take the world on under yourterms.

Experience the world on yourown terms with Curador Flowerand Vape Products.

Carefully curated strains offerbold aromatics and vibrantflavors that bring power andprestige to every interation.

Choose your path. Choose yourfuture. Choose Curador.

“The Essence of Wellness”

Rising from Mother Earth givingthe essence of pure, naturalwellness while elevating yourspirit to live life on your terms.

Every carefully crafted Terapiatopical and edible is made with the finest ingredients that mother earth has to offer. From luscious Terapia Topicals that comfort your skin to scrumptious Terapia Edibles that tantalize the taste buds and nourish your body, Terapia is made to make you feel incredible.

Experience Terapia and show the world the real YOU

Unique, Independent, Personal Courageous, Bold, Determined Green Spirit Rx Vibrant, Beautiful, Healthy


LEADERSHIP

Eli DusenburyChief Financial Officer

Eli Dusenbury has extensiveexperience as CFO of both publicand private company’s in Canadaand the US over a broad range ofindustries since obtaining hisChartered Accounting designation in2010. Previous to CFO consulting, heworked as an audit manager at botha Canadian and US audit firm with afocus on large scale manufacturingand technology under publicreporting standards of Canada andthe US.

Josh RosenbergPresident

Josh Rosenberg is a formerExecutive in the Coca-Cola systemfor over 18 years developing hisskills from merchandising, service,call center management, sales,marketing, and operational roles.Josh left in 2013 to invest and leadas CEO at Accent Food Services anddeveloping from a single stateoperation to one of the largestmulti-state operators in the OfficeCoffee Services (OCS) Industry. Oversix years top line revenue, grewmore than 6x’s, adding strategicacquisitions, and building a strongculture before moving to an activeadvisory role in 2019.

Edgar MonteroChief Executive Officer

Edgar Montero has over 15 years ofexperience in business developmentand has a robust background in bothdirect sales and employeedevelopment. As the previous CEONatural Ventures, Mr. Montero isheavily immersed in the growth ofthe medical cannabis industry inPuerto Rico, where he helpedestablish one of the largest cannabisoperations in the Caribbean.

Shaun DaleVP of Operations

Shaun Dale joined ChemesisInternational in January 2019, as VPOf Operations for America. Shaunbrings 25 years of operationalmanagement experience to theindustry. Shaun’s proven track ofsuccess brings stability and growthto Chemesis as we expandoperations in the US market. Shaunis responsible for the developmentand implementation of legal andcompliant cannabis facilities in theUnited States.


LEGALThe information contained in this presentation (“Presentation”) has been prepared by Chemesis International and is being communicated for general background informational purposesonly. Except as required by applicable law, the Presentation has not been independently verified and the information contained within is subject to updating, completion, revision,verification and ongoing amendment. Neither Chemesis International, nor its shareholders, directors, officers, agents, employees, or advisors give, has given or has authority to give, anyrepresentations or warranties (express or implied) as to, or in relation to, the accuracy, reliability or completeness of the information in this Presentation, or any revision thereof, or of anyother written or oral information made or to be made available to any interested party or its advisers (all such information being referred to as “Information”) and liability therefore isexpressly disclaimed. Neither the communication of this Presentation nor any part of its contents is to be taken as any form of commitment on the part of Chemesis International toproceed with any transaction. This Presentation does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer to subscribe for or purchase anysecurities in Chemesis International, nor shall it, or the fact of its communication, form the basis of, or be relied upon in connection with, or act as any inducement to enter into, anycontract or commitment whatsoever with respect to such securities. In furnishing this Presentation, Chemesis International does not under- take or agree to any obligation to provide theattendee with access to any additional information or to update this Presentation or to correct any inaccuracies in, or omissions from, this Presentation that may become apparent eitherduring, or at any time after this Presentation. Certain statements contained herein constitute “forward-looking information.” Forward-looking information look into the future and can beidentified by words such as “plans,” “intends,” anticipates,” “should,” “estimates,” “expects,” “believes,” “indicates,” “targeting,” “suggests,” “potential,” and similar expressions. Statementsinvolving forward-looking information are based on current expectations and entail various risks and uncertainties. Actual results may vary from the forward–looking information andmaterially differ from expectations, if known and unknown risks or uncertainties affect our business, or if our estimates or assumptions prove inaccurate.

Certain information contained in this Presentation with respect to other industries and their business operations and data has been obtained or quoted from publicly available sources,such as continuous disclosure documents, independent publications, media articles, third party websites (collectively, the “Publications”). In certain cases, these sources make norepresentations as to the reliability of the information they publish. Further, the analyses and opinions reflected in these Publications are subject to a series of assumptions about futureevents. There are a number of factors that can cause the results to differ materially from those described in these publications. None of Chemesis International or its representativesindependently verified the accuracy or completeness of the information contained in the Publications or assume any responsibility for the completeness or accuracy of the informationderived from these Publications.

CSE: CSI | OTC:CADMF | FRA:CWAACSE: CSI | OTC:CADMF | FRA:CWAA

THANK YOU FORYOUR INTEREST

CHEMESIS INTERNATIONAL Inc.2710-200 Granville StreetVancouver, British Columbia V6C 1S4

INVESTOR RELATIONSEmail: [email protected]: +1 604.398.3378

CSI: CSECADMF: OTCMKTSCWAA: FRA

www.chemesis.com

http://chemesis.com

making waves in todays cannabis industry€¦ · cse: csi | otc:cadmf | fra:cwaa making waves in...

Documents